Actively Recruiting
Fluorescence-Guided Optimization of Sarcoma Margins
Led by University of Aarhus · Updated on 2025-12-04
90
Participants Needed
2
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Danish national multicenter prospective cohort study to evaluate if fluorescence-guided surgery (FGS) using indocyanine green (ICG) can reduce the rate of positive margins following sarcoma resection.
CONDITIONS
Official Title
Fluorescence-Guided Optimization of Sarcoma Margins
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Biopsy verified intermediate-to-high grade sarcoma of the extremity or trunk wall
- Age greater than 18 years old
- Tumor must be operable
- Surgery must be planned with curative intent
- Patient must provide consent
You will not qualify if you...
- History of allergic reaction to iodine-containing pharmaceuticals
- End-stage renal disease or eGFR less than 15
- Patient decision to not participate
- Lack of capacity to consent or participate
- Tumor judged inoperable
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Aarhus University Hospital
Aarhus N, Denmark, 8200
Actively Recruiting
2
Rigshospitalet
Copenhagen, Denmark, 2100
Not Yet Recruiting
Research Team
C
Christian Kveller, MD
CONTACT
T
Thomas Baad-Hansen, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here